When clinical supply reveals a constraint, someone must decide what it means for patients and data. Strong governance turns those signals into accountable action.
- When IRT Configuration Decisions Disrupt Clinical Supply
- Fixing The Data Problem Before AI Can Help Clinical Trial Supply
- The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries
- Building Stronger Sponsor–Vendor Relationships
- When Clinical Supply Plans Meet Site Reality: Lessons From The Front Line
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- Managing Customs, Import/Export Requirements, And Cross-Border Logistics Challenges
- July Update — U.S. Generic Drug Tariffs: Implications For Pharma And Outsourcing
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
How Modern RTSM Platforms Are Eliminating Delays
Stop letting rigid legacy RTSM systems stall your clinical trials. Learn why manual change requests cause months of delays and how a modern, platform-based approach restores your study’s agility.
-
Is Your Clinical Supply Strategy Ready For EU CTR?
One of the most significant changes in the new EU regulation is Annex VI, which covers changes in the labelling requirements for investigational medical products (IMPs). So, what are the implications of these changes and how will they affect outer immediate packaging?
-
Improving Clinical Trial Label Translation Through Centralized Reuse And Control
Eliminate workflow inefficiencies and regulatory risk in global trials with a centralized translation framework and validated phrase library for consistent, cost-effective execution.
-
Cryobag Container Development For Cell & Gene Therapies
ISR Reports addresses the logistical challenges faced by developers of cell and gene therapies regarding cold chain and cryopreservation.
-
Building A Global Cell And Gene Supply Chain Serving Personalized Medicine
Clinical distribution paths can be fragile for a multitude of reasons, making it critical that pharmaceutical sponsors and their partners orchestrate supply chain logistics even before site initiation.
-
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution
Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
Sponsor Overcomes Hold And Steers Products Through Development
Uncover how a small-sized biotech company was able to resolve critical regulatory CMC deficiencies to meet FDA requirements.
-
Enhancing Quality And Efficiency Through Digitized Clinical Secondary Packaging Processes
Explore how an innovative software platform can be used to create customized, user-friendly applications to digitize clinical secondary packaging processes.
-
How Clinical Trial Complexity Impacts End Users
This article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
Decentralized Trials: The Value Of Direct-To-Patient, Pharmacy-Led Solutions
Pharmacy-led DTP models cut site burden, improve inventory control, and expand trial access. Learn how to optimize your decentralized trial supply chain for compliance and patient outcomes.
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.